NasdaqCM - Nasdaq Real Time Price USD

The Beauty Health Company (SKIN)

Compare
1.6900 +0.0600 (+3.68%)
As of 10:12 AM EDT. Market Open.
Currency in USD All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
366,231.0000
397,991.0000
365,876.0000
260,086.0000
119,092.0000
--
Cost of Revenue
243,797.0000
242,878.0000
117,097.0000
81,548.0000
51,893.0000
--
Gross Profit
122,434.0000
155,113.0000
248,779.0000
178,538.0000
67,199.0000
--
Operating Expense
261,997.0000
286,030.0000
274,620.0000
218,466.0000
84,381.0000
--
Operating Income
-139,563.0000
-130,917.0000
-25,841.0000
-39,928.0000
-17,182.0000
--
Net Non Operating Interest Income Expense
10,407.0000
9,524.0000
-4,217.0000
-11,738.0000
-21,275.0000
--
Other Income Expense
48,528.0000
19,504.0000
75,397.0000
-328,973.0000
-26.0000
--
Pretax Income
-80,628.0000
-101,889.0000
45,339.0000
-380,639.0000
-38,483.0000
--
Tax Provision
3,070.0000
-1,773.0000
1,115.0000
-1,875.0000
-9,308.0000
--
Net Income Common Stockholders
-83,698.0000
-100,116.0000
44,224.0000
-378,764.0000
-29,175.0000
--
Average Dilution Earnings
-27,722.0000
--
-78,343.0000
--
--
--
Diluted NI Available to Com Stockholders
-111,420.0000
-100,116.0000
-34,119.0000
-378,764.0000
-29,175.0000
--
Basic EPS
-0.63
-0.76
0.30
-3.67
-0.23
--
Diluted EPS
-0.83
-0.76
0.23
-3.67
-0.23
--
Basic Average Shares
127,104.6770
131,680.6050
147,554.0900
102,114.8830
125,399.9130
--
Diluted Average Shares
136,996.1110
131,680.6050
148,506.3120
102,114.8830
125,399.9130
--
Total Operating Income as Reported
-139,563.0000
-130,917.0000
-25,841.0000
-39,928.0000
-17,182.0000
--
Total Expenses
505,794.0000
528,908.0000
391,717.0000
300,014.0000
136,274.0000
--
Net Income from Continuing & Discontinued Operation
-83,698.0000
-100,116.0000
44,224.0000
-378,764.0000
-29,175.0000
--
Normalized Income
-91,903.7300
-114,176.8320
-30,973.8720
-55,902.4200
-29,190.9207
--
Interest Income
22,691.0000
23,173.0000
9,175.0000
39.0000
--
--
Interest Expense
12,284.0000
13,649.0000
13,392.0000
11,777.0000
21,275.0000
--
Net Interest Income
10,407.0000
9,524.0000
-4,217.0000
-11,738.0000
-21,275.0000
--
EBIT
-68,344.0000
-88,240.0000
58,731.0000
-368,862.0000
-17,208.0000
--
EBITDA
-32,820.0000
-56,001.0000
80,747.0000
-351,079.0000
-2,807.0000
--
Reconciled Cost of Revenue
243,797.0000
242,878.0000
117,097.0000
81,548.0000
51,893.0000
--
Reconciled Depreciation
35,524.0000
32,239.0000
22,016.0000
17,783.0000
14,401.0000
--
Net Income from Continuing Operation Net Minority Interest
-83,698.0000
-100,116.0000
44,224.0000
-378,764.0000
-29,175.0000
--
Total Unusual Items Excluding Goodwill
10,387.0000
14,304.0000
77,047.0000
-324,484.0000
21.0000
--
Total Unusual Items
10,387.0000
14,304.0000
77,047.0000
-324,484.0000
21.0000
--
Normalized EBITDA
-43,207.0000
-70,305.0000
3,700.0000
-26,595.0000
-2,828.0000
--
Tax Rate for Calcs
0.0002
0.0000
0.0000
0.0000
0.0002
--
Tax Effect of Unusual Items
2,181.2700
243.1680
1,849.1280
-1,622.4200
5.0793
--
12/31/2019 - 11/24/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers